Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2026-04-23

Clinical Trial Update: A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 pediatric acute myeloid leukemia trial of venetoclax in combination with conventional chemotherapy is suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Venclexta (venetoclax) (venetoclax)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: SUSPENDED